Blog - Page 3053 of 5753

MondayJul 08, 2013 4:24 pm

The Aristocrat Group Corp. (ASCC) Seeks New “Top Drink”

It is surprising to many that vodka, now the most popular hard liquor in America, was almost unknown in the U.S. prior to World War II. The first U.S. distillery wasn’t even set up until the 1930s, and it was only well after the War, in the 50s and 60s, that vodka began to get significant recognition in the U.S. In a food and beverage world where taste dominated, it was vodka’s unique lack of taste that made it the perfect mixer and helped drive its popularity. Vodka can mix with virtually anything, achieving dramatically different creations depending upon the…

MondayJul 08, 2013 2:28 pm

Rafarma Pharmaceuticals, Inc. (RAFA) Targets Fair Share of Russia’s Rapidly Growing Pharmaceutical Market

Rafarma Pharmaceuticals constructed and now operates a 270,000-square foot multi-purpose pharmaceutical facility in Russia in direct response to the Russian Government’s plan to significantly advance the domestic pharmaceutical industry in the Russian Federation. In a recent video interview with the QualityStocks Production team, Rafarma CEO Sergey Brunsnitsyn details the operations and qualification of the production plant, how it meets world standards in the field of pharmaceuticals and industrial construction, and the company’s strategy to secure 5 percent of market share in the Russian pharmaceuticals market by 2017. “The strategies of the company, the professional team, the modern production facilities and…

MondayJul 08, 2013 2:18 pm

Cell Therapeutics, Inc. (CTIC) PIXUVRI® Granted Market Access in Italy, Provides Solution for Multiply Relapsed, Aggressive non-Hodgkin Lymphoma

Cell Therapeutics, the Seattle-based biopharma developer focused on targeted oncology therapeutics which cover a broad spectrum of blood-related cancers, was excited to report today that their revolutionary anti-lymphoma compound, PIXUVRI® (Pixantrone), has been cleared for access to Italian markets by the nation's primary regulatory body, the AIFA (Italian Medicines Agency), following the adoption last year in May by the EC (European Commission) of conditional marketing authorization status for the EU. PIXUVRI's original market authorization in the EU, as a monotherapy for adults with aggressive B-cell NHL (non-Hodgkin lymphoma), where the patient has failed prior therapy lines, is extended here via…

MondayJul 08, 2013 12:25 pm

GNCC Capital, Inc. (GNCP) Business Model Supported by Industry Experienced Leadership

GNCC Capital is focused on its gold and three silver exploration projects in Arizona. The company’s team of geologists supervises the exploration program designed to prove up reserves through geological surveys and drilling programs. While the company’s primary focus is gold exploration, it is also seeking opportunities in other minerals and aims to grow through acquisitions of promising gold mining properties in the United States. GNCC Capital’s business model also allows for consideration of serious joint ventures on any of its portfolio assets. Company CEO Nicolaas Edward “Ted” Blom has more than 25 years of experience in mining and energy,…

MondayJul 08, 2013 12:20 pm

VentriPoint Diagnostics Ltd. (VPTDF) Expands Target Market to Include Pulmonary Hypertension

A unique ultrasound-based system for performing right heart analysis, developed by VentriPoint Diagnostics and now used in various hospitals around the world, is also being developed and introduced as a superior approach to diagnose pulmonary hypertension (PH), an unhealthy increase in blood pressure in the pulmonary artery or pulmonary vein which can lead to a variety of problems, up to and including heart failure. The VentriPoint VMS system, called Angelo, uses 2-dimensional ultrasound data, together with a patented system called Knowledge-Based Reconstruction (KBR) for analyzing that ultrasound data. The result is an information-rich 3-dimensional model of the heart. For right…

MondayJul 08, 2013 10:58 am

Mabwe Minerals Inc. (MBMI) Targets the Middle East, Europe, and More

Mabwe Minerals, together with a number of key partners, is busy developing a world-class deposit of barite (BaSO4) in Zimbabwe in southern Africa. The company’s Dodge Mine project in northeast Zimbabwe is the current focus, where ASCON validation studies of just one part of the property indicate 411,000 tons of barite and 531,000 tons of limestone, representing a current market value of approximately $79 million, just for a start. Baker Hughes, Inc., one of the world’s top-tier oilfield service companies, has already lined up as a major buyer, looking for roughly 3 million metric tons at 220,000 tons annually for…

MondayJul 08, 2013 10:34 am

Joe’s Jeans Inc. (JOEZ) Video Chart for Monday, July 8, 2013

JOEZ is holding a firm support level around $1.50 and the indicators are trying to turn. The chart faces a challenge at static and dynamic resistance at $1.70, but a break above that level could signal a run at 52-week highs. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

MondayJul 08, 2013 9:50 am

International Stem Cell Corp. (ISCO) Proprietary Stem Cell Technology Creates Unique Business Portfolio

International Stem Cell is a 12-year old biotech company headquartered in Carlsbad, Calif., focused on the development of therapeutic, biomedical and cosmeutical products for both domestic and international commercialization. The company’s operations branch into two channels. The first is developing products based on human parthenogenetic stem cells which the company develops into other cell types such as liver cells for the treatment of congential and acquired liver diseases; islet cells for the treatment of diabetes; neuronal cells for the treatment of Parkinson’s disease and other central nervous system disorders; and 3 dimensional eye structures to treat degenerative retinal diseases, corneal…

MondayJul 08, 2013 8:43 am

Rafarma Pharmaceuticals, Inc. (RAFA) Enters Production Agreement to Manufacture Pharmaceutical Product

Rafarma Pharmaceuticals announced that it entered into a production agreement last month to manufacture Para-Aminosalicylic Acid (PAS), which is to be marketed and distributed by OOO Advance Trading. Rafarma aims to work with federal initiatives to fast track the modernization of Russia's pharmaceutical industry. It produces generic antibiotics, specialty pharmaceuticals, and its own line of proprietary products, which have been approved by the Russian Federation’s Ministry of Health. Working with Advanced Trading will allow Rafarma to increase production of PAS and to become one of the leading PAS suppliers throughout the Russian market. As one of Russia’s leading PAS distributors,…

MondayJul 08, 2013 8:32 am

Solar Wind Energy Tower, Inc. (SWET) Issues Statement from CEO Ronald W. Pickett

Solar Wind Energy Tower, the inventor of a large Solar Wind Downdraft Tower structure capable of producing inexpensive electricity, today disseminated the following investor-focused statement from Ron Pickett, CEO: A CNBC.COM article entitled "Second Wind: Renewable Energy Down but Not Out," written by Javier E. David, appeared on June 30. David reports: "Two events occurred that could point to a new second wind for the battered alternative energy sector. President Obama unveiled a broad swath of measures to combat carbon emissions, including new funding for clean energy technology and setting a goal to double the amount of electricity generated by…

Site Search

Company Search